Immune-Inflammation in Atherosclerosis: A New Twist In An Old Tale.
Atherosclerosis, a chronic and progressive inflammatory disease, is triggered by the activation of endothelial cells followed by infiltration of innate and adaptive immune cells including monocytes and T cells in arterial walls. Major populations of T cells found in human atherosclerotic lesions are antigen-specific activated CD4+ effectors and/or memory T cells from Th1, Th17, Th2 and Treg subsets. In this review we will discuss the significance of T cell orchestrated immune inflammation in the development and progression of atherosclerosis. Pathogen/oxidative stress/lipid induced primary endothelial wound cannot develop to a full blown atherosclerotic lesion in the absence of chronically induced inflammation. While the primary inflammatory response might be viewed as a lone innate response, the persistence of such a profound response over time must be (and is) associated with diverse local and systemic T cell responses. The interplay between T cells and innate cells contributes to a phenomenon called immune-inflammation and has an impact on the progression and outcome of the lesion. In recent years immune-inflammation, an old term, has had a comeback in connecting the puzzle pieces of chronic inflammatory diseases. Taking one step back and looking from afar at the players of immune-inflammation may help us provide a broader perspective of these complicated interactions. This may lead to identification of new drug targets and development of new therapies as well as preventative measures.